- *ST天山生物
- 8.340-0.010 (-0.120%)
盈利能力分析
- -76.429
- -225.890
- -30.069
- -33.810
- -21.075
- -4.451
- -23.410
- -6.793
- -8.700
- -4.180
- -7.748
- -55.083
- -13.037
- -14.583
- -8.625
邊際利潤分析
- 19.947
- -5.230
- 16.986
- 14.166
- 7.089
- -12.960
- -44.576
- -13.572
- -36.988
- -26.047
- -0.750
- -38.280
- -6.278
- -21.879
- -13.434
- -18.749
- -48.748
- -16.061
- -41.952
- -28.149
收益指標分析
- 165.000
- 73.168
- 80.289
- 73.521
- 117.534
- -28.772
- -5.374
- -15.069
- 26.411
- -2.921
- 3.175
- 3.255
- 3.340
- 7.324
- 1.479
償債能力分析
- 1.036
- 0.321
- 0.484
- 0.521
- 0.633
- 0.295
- 0.226
- 0.168
- 0.281
- 0.527
- 83.933
- 97.711
- 77.162
- 71.714
- 71.353
- 32.910
- 85.081
- 50.434
- 47.535
- 53.899
- 48.531
- -5.126
- 80.674
- 95.850
- 76.713
- 14.765
- -1.558
- 25.559
- 35.290
- 36.558
- -0.059
- -4.910
- -0.809
- -1.213
- -1.033
營運能力分析
- 63.070
- 34.041
- 25.984
- 82.715
- 61.330
- 250.337
- 113.040
- 199.698
- 228.050
- 133.930
大國博弈
回顧25 展望26
More